These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11362673)

  • 1. HIV/TB dual infection cause for concern.
    Servilio J
    Posit Aware; 1995; ():8. PubMed ID: 11362673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonging survival among MDR-TB AIDS patients.
    AIDS Alert; 1995 Jul; 10(7):91-3. PubMed ID: 11362556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of regimens for treating tuberculosis in patients with HIV infection, with particular reference to sub-Saharan Africa.
    Harries AD; Hargreaves NJ; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1109-15. PubMed ID: 11769768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new tuberculosis.
    De Cock K
    Afr Health; 1994 Mar; 16(3):8-10. PubMed ID: 12318774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(34):585-91. PubMed ID: 1870559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
    Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India.
    Swaminathan S; Padmapriyadarsini C; Sukumar B; Iliayas S; Kumar SR; Triveni C; Gomathy P; Thomas B; Mathew M; Narayanan PR
    Clin Infect Dis; 2008 Mar; 46(6):946-9. PubMed ID: 18279043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.
    Wejse C; Furtado A; Camara C; Lüneborg-Nielsen M; Sodemann M; Gerstoft J; Katzenstein TL
    Int J Infect Dis; 2013 Oct; 17(10):e907-12. PubMed ID: 23816410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis epidemic poses international threat. World Health Organization.
    AIDS Wkly Plus; 1995 Nov 20-27; ():24-5. PubMed ID: 12290613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
    Stout JE
    Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
    Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W
    J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TB news.
    Posit Aware; 1996; 7(1):6-7. PubMed ID: 11363128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thai drug-resistant tuberculosis predictive scores.
    Boonsarngsuk V; Tansirichaiya K; Kiatboonsri S
    Singapore Med J; 2009 Apr; 50(4):378-84. PubMed ID: 19421681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A short two-drug regimen prevents active TB.
    Torres G
    GMHC Treat Issues; 1998 Apr; 12(4):12. PubMed ID: 11365399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chapter 4: childhood contact screening and management.
    World Health Organization Stop TB Partnership Childhood TB Subgroup
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):12-5. PubMed ID: 17217124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.